Oncopeptides (Sweden) Analysis
| ONCO Stock | SEK 1.69 0.03 1.81% |
Oncopeptides AB is overvalued with Real Value of 1.5 and Hype Value of 1.69. The main objective of Oncopeptides stock analysis is to determine its intrinsic value, which is an estimate of what Oncopeptides AB is worth, separate from its market price. There are two main types of Oncopeptides' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Oncopeptides' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Oncopeptides' stock to identify patterns and trends that may indicate its future price movements.
The Oncopeptides stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Oncopeptides is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Oncopeptides Stock trading window is adjusted to Europe/Stockholm timezone.
Oncopeptides |
Oncopeptides Stock Analysis Notes
About 48.0% of the company shares are owned by institutional investors. The book value of Oncopeptides was now reported as 4.21. The company recorded a loss per share of 16.78. Oncopeptides AB had not issued any dividends in recent years. Oncopeptides AB , a pharmaceutical company, develops drugs for the treatment of cancer. The company was founded in 2000 and is headquartered in Stockholm, Sweden. Oncopeptides is traded on Stockholm Stock Exchange in Sweden. To find out more about Oncopeptides AB contact the company at 46 86 15 20 40 or learn more at https://www.oncopeptides.com/sv.Oncopeptides AB Investment Alerts
| Oncopeptides AB generated a negative expected return over the last 90 days | |
| Oncopeptides AB may become a speculative penny stock | |
| Oncopeptides AB has high historical volatility and very poor performance | |
| Oncopeptides AB has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 118.3 M. Net Loss for the year was (1.43 B) with profit before overhead, payroll, taxes, and interest of 74.16 M. | |
| Oncopeptides AB has accumulated about 747.47 M in cash with (1.52 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.3, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Oncopeptides Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 933.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oncopeptides's market, we take the total number of its shares issued and multiply it by Oncopeptides's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 29th of November, Oncopeptides holds the Risk Adjusted Performance of (0.05), variance of 15.9, and Coefficient Of Variation of (1,358). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncopeptides, as well as the relationship between them.Oncopeptides AB Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oncopeptides middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Oncopeptides AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Oncopeptides Outstanding Bonds
Oncopeptides issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Oncopeptides AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Oncopeptides bonds can be classified according to their maturity, which is the date when Oncopeptides AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Oncopeptides Predictive Daily Indicators
Oncopeptides intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oncopeptides stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Oncopeptides Forecast Models
Oncopeptides' time-series forecasting models are one of many Oncopeptides' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oncopeptides' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Oncopeptides Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oncopeptides prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oncopeptides shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oncopeptides. By using and applying Oncopeptides Stock analysis, traders can create a robust methodology for identifying Oncopeptides entry and exit points for their positions.
Oncopeptides AB , a pharmaceutical company, develops drugs for the treatment of cancer. The company was founded in 2000 and is headquartered in Stockholm, Sweden. Oncopeptides is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Oncopeptides to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Oncopeptides Stock Analysis
When running Oncopeptides' price analysis, check to measure Oncopeptides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncopeptides is operating at the current time. Most of Oncopeptides' value examination focuses on studying past and present price action to predict the probability of Oncopeptides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncopeptides' price. Additionally, you may evaluate how the addition of Oncopeptides to your portfolios can decrease your overall portfolio volatility.